Benign prostate hypertrophy (BPH) has an impact on quality of life and symptoms are crucial in causing bother. Therefore a patient’s concerns of the disease, and his subjective ranking of therapeutic priorities should be elicited, and the patient’s expectancies should be considered. Objective: to describe patients’ concerns regarding symptoms severity and treatment of BPH. Setting: The study was carried out at the Urologic Outpatient Department of the Health Insurance Hospital in Alexandria, Egypt. Subjects: A convenience sample of 100 adult male patients diagnosed with benign prostate hypertrophy were recruited to participate in the study. Tools: a structured interview schedule was used in this study including bio-sociodemographic data, the International Prostate Symptom Score (IPSS); additional questions relating to patients’ concerns about symptoms severity and treatment of enlarged prostate. Results: The findings indicated that more than half of the patients (52%) had moderate lower urinary tract symptom severity (LUTS). The main concerns first experienced by patients seeking medical advice for symptoms of BPH were the impact of symptoms on social and professional life, fear of cancer, frustration and embarrassment caused by symptoms. The main concerns of a large number of patients when taking medication were the ability of medication to reduce the risk of surgery and relieve symptoms within few weeks or months. Conclusion: This study provides a valuable insight into the concerns of patients regarding BPH and its management. Moreover, it emphasizes the need for consideration of patient preferences during clinical decision-making. Recommendations: The study recommended that it is vital that health teams assess and fully understand their patients’ satisfaction with BPH treatment, their preferred treatment options and expectations